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 In a new paper in  PLoS Medicine , Fretheim and colleagues report the results of the Rational 
Prescribing in Primary Care 
(RaPP) trial, a cluster-randomised 
controlled trial of a multicomponent 
intervention to improve prescribing 
of antihypertensive and cholesterol-
lowering drugs in primary care [1]. 
In a second paper, the same authors 
present their economic evaluation of 
the intervention [2].
 In the trial, the unit of 
randomization was the general 
practice, and the authors randomized 
146 general practices from two 
geographical areas to the intervention 
or control. The multicomponent 
intervention included educational 
outreach visits to clinics to discuss 
clinical practice guidelines, an audit 
and feedback on current adherence 
to guidelines, and computerized 
reminders to doctors during patient 
consultations. The control intervention 
was passive dissemination of guidelines 
through a national medical journal.
 Trial Outcomes
 The trial was meticulously executed, 
with large numbers and a well-
designed intervention. Essentially, it 
was a negative trial. The intervention 
had no impact upon two major 
outcomes: (1) the proportion of 
patients in whom cardiovascular risk 
was estimated, among all those started 
on antihypertensive or cholesterol-
lowering treatment for primary 
prevention, and (2) the proportion 
of patients with a recorded level 
of cholesterol (total or low-density 
cholesterol) or blood pressure 
satisfying the speciﬁ ed treatment 
goals, among all patients on the 
corresponding treatment for at least 
three months. The only positive 
outcome was that the intervention led 
to increased prescribing of thiazide 
diuretics as a ﬁ rst-line treatment, 
something that is already being 
addressed as a policy issue by the 
government in Norway and in a 
number of other countries. 
 So on the face of it, this is a negative 
trial. Doctors were no more likely to 
use cardiovascular risk assessment, even 
when provided with pop-up reminders 
on their computerized medical 
records and with software designed 
to provide the necessary calculations 
automatically. 
 Implications of the Study
 However, the increase in prescribing of 
thiazide diuretics as a ﬁ rst-line treatment 
for the hypertension that contributed 
to increased cardiovascular risk needs 
careful consideration. The increase 
was by 12% overall, increasing the total 
rate from 5% to only 17% of patients 
in the intervention group. At ﬁ rst, this 
must seem very disappointing. As a 
profession, we doctors underuse a very 
effective and safe drug, and despite the 
development of much more expensive 
alternatives—heavily promoted by the 
drug industry—thiazide is the drug of 
ﬁ rst choice. Thus, 17% seems a very 
modest achievement with so much 
effort. One might be forgiven for 
becoming despondent. 
 And yet this multicomponent 
intervention is perhaps the best 
attempt that could ever be made at 
increasing the quality of care for a 
single condition in primary care. The 
intervention seems to have covered 
all bases, including using print 
material and guidelines [3], audit and 
feedback [4], and “outreach” visits 
[5]—each of which the literature is 
only mildly optimistic about. Moreover, 
hypertension is the most common 
chronic condition requiring long-term 
prescribing in primary care. Little more 
could have been done without invoking 
draconian measures, such as legislation. 
 The results of this study seem to ﬁ t 
with the recurrent theme of doctors’ 
professional behaviour being hard 
to shift [6]. Doctors often work by 
heuristics (i.e., using rules of thumb 
and trial and error) rather than 
always following established care 
pathways. And when it comes to 
caring for patients, doing more (e.g., 
prescribing the latest brand name 
antihypertensives) may just feel better 
than doing less (e.g., prescribing an 
“old fashioned” thiazide), even if doing 
more turns out to be more costly. If this 
is true, then drug industry advertising 
will tend to have a greater effect upon 
doctors’ prescribing patterns than 
exhortations to use cheaper drugs. 
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 Drug ads will tend to 
have a greater effect 
on doctors’ prescribing 
than exhortations to use 
cheaper drugs. 
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 Were such small gains worth the 
effort? The answer comes in the 
second paper [2]. An economic 
analysis ﬁ nds that although the 
costs of the intervention were much 
more than the savings represented 
by the use of thiazides rather than 
the more expensive alternatives in 
the short term, one only had to wait 
two years for the savings to outweigh 
the costs. This two-year cost saving is 
astonishing for such a small change in 
prescribing. 
 Conclusion
 It seems that the effort of throwing 
everything at doctors (except, perhaps, 
ﬁ nancial incentives [7]) is only 
very modestly effective in terms of 
improved clinical behaviour. However, 
it is nevertheless cost-effective. More 
than that, it is cost saving. And that 
being the case, it is almost criminal 
not to implement the intervention 
everywhere. We must surely also 
explore whether the intervention 
would be beneﬁ cial for managing other 
conditions in primary care. 
 And as a ﬁ nal thought, these 
economic equations make one 
realise why drug companies spend so 
much money on persuading doctors 
to use their modern but expensive 
alternatives. In this case, the cost 
differential was as beneﬁ cial to their 
shareholders as the savings were to the 
Norwegian government.  
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